Mostafa ronaghi biography sample

Experience: Summit Therapeutics, Inc. Mostafa Ronaghi (Persian: مصطفی رونقی; born ) is an Iranian molecular biologist, specializing in DNA sequencing methodology. He earned his Ph.D. from the Royal Institute of Technology in Sweden in

Pyrosequencing sheds light on

Dr. Ronaghi is the Co-Founder and Executive Board Member of Cellanome. Prior to founding Cellanome, he was Chief Technology Officer, Senior Vice President, and member of the Executive Leadership Team at Illumina, Inc. (Nasdaq: ILMN) from to

Mostafa Ronaghi's 3 research The samples from the American veterans contained six different subtypes, while five subtypes were found in Iranian samples. For rapid population-specific HCV subtyping, a multiplex assay was.

Ronaghi, RW Davis. US Patent 6,858,412, Mostafa Ronaghi, Ph.D., joined Illumina in August As Senior Vice President and Chief Technology Officer, he is responsible for leading internal research and the Illumina accelerator program. Dr. Ronaghi is an experienced entrepreneur and was involved in the start-up of four life sciences companies.

Ronaghi, a serial entrepreneur who A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing P Parameswaran, R Jalili, L Tao, S Shokralla, B Gharizadeh, M Ronaghi, Nucleic.

Mostafa Ronaghi's 209 research Mostafa Ronaghi received the Ph.D. degree from the Royal Institute of Technology, Stockholm, Sweden. He is a molecular biologist, specializing in DNA sequencing methodology. He is currently the Chief Technology Officer and Senior Vice President at Illumina.

Dr. Ronaghi spoke of how Mostafa Ronaghi is Senior Vice President and Chief Technology Officer of Illumina, Inc., a leading publicly traded, life sciences company. Dr. Ronaghi joined Illumina following their acquisition of Avantome, Inc., which was his fourth life sciences start-up company.

Senior VP of Engineering Show Bio. Mostafa Ronaghi. Mostafa Ronaghi (Persian: مصطفی رونقی; born ) is an Iranian molecular biologist, specializing in DNA sequencing methodology. He earned his Ph.D. from the Royal Institute of Technology in Sweden in As of , he is the Chief Technology Officer and Senior Vice President at Illumina. [1].